This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to ...

There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.

Biotech stocks may be primed for a long-term bull run. Learn why IBB, XBI, and macro trends like rate cuts make biotech an ...

In a sign it is willing to go further in responding to President Trump’s tariffs, Beijing blocked more American companies ...

The United States has been the undisputed innovator and leader in biology and biotechnology ... Just as we have experienced with other US innovations, from solar panels and batteries to computer ...

US President Donald Trump's second term is expected to bring widespread changes. In the biotech industry ... In a post on X after his October nomination, Kennedy issued a warning: “FDA ...

US biotech Excision BioTherapeutics has raised $60 million to test a potential HIV cure in the clinic, which would use CRISPR technology to snip out the viral code from human cells and tissues.

Although a federal judge has temporarily blocked the policy change, government grants to early-stage biotech startups could still face delays or be eliminated entirely, said Chris Gibson ...